FDA denies approval of weight-loss drug Contrave
Tuesday, February 1, 2011 - 20:20
in Mathematics & Economics
The agency keeps the drug off the market, citing possible cardiovascular problems in users. This is the third weight-loss drug the agency has turned away in recent months.Ignoring the recommendation of its own advisory committee, the Food and Drug Administration on Tuesday declined to approve the weight-loss drug Contrave, the third such drug the agency has kept off the market in recent months.